© Medpharm. Limited treatment options are available for HIV-infected paediatric patients that are virologically failing combination antiretroviral treatment (cART). This paper describes the use of lamivudine monotherapy (LM) as a holding strategy for the short-term treatment of specific multi-drug resistant paediatric patients, where a definite suppressive cART regimen is not possible. Lamivudine monotherapy should only be used under close supervision and monitoring of an expert HIV clinician.
|Number of pages||3|
|Journal||SA Pharmaceutical Journal|
|Publication status||Published - 1 Jan 2015|
- Holding regimen
- Lamivudine monotherapy
- Paediatric ART
- Virological failure